Global Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market Share, Size, Future Outlook, COVID-19 Impact Analysis, Forecast

1. Orion Market Research Global Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market Share, Size, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027 Request a Free Sample of our Report on Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market: https://www.omrglobal.com/request-sample/dipeptidyl-peptidase-4-inhibitors-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

2. The global dipeptidyl peptidase 4 (DPP-4) inhibitors market is anticipated to grow significantly at a CAGR of 3.5% over the forecast period (2020-2026). The global dipeptidyl peptidase 4 (DPP-4) inhibitors market is sectioned on the basis of drug type. The market is sectioned as Sitagliptin, Vildagliptin, Saxagliptin, Linagliptin, Gemigliptin, Anagliptin, Teneligliptin, and Others. Amongst these drug types of the global dipeptidyl peptidase 4 (DPP- 4) inhibitors, the Sitagliptin and Saxagliptin are projected to hold the most lucrative share in the market. The key aspects that drive the segmental growth of the dipeptidyl peptidase 4 (DPP-4) inhibitors market include the effectiveness of the drugs. As per the NCBI NLM, the Sitagliptin and Saxagliptin drugs hold the lucrative share in the market owing to their effectiveness on the patients. (Get 15% Discount on Buying this Report) Get Report Sample Copy @ https://www.omrglobal.com/request-sample/dipeptidyl- peptidase-4-inhibitors-market There has been an upsurge witnessed in the prevalence of diabetes across the globe. As per the WHO, over the last three decades there has been an upsurge in the prevalence of diabetes. As per the IDF, the cases of diabetic were nearly 463 million across the globe in 2019. The cases are projected to increase which is expected to rise to 578 million by 2030 and nearly 700 million by 2045. An increase in the prevalence of diabetes is likely to demand the proper drugs for the treatment. Thus, owing to the market is likely to witness an upsurge over the forecast period. A Full Report of Global Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market is Available at: https://www.omrglobal.com/industry-reports/dipeptidyl-peptidase-4-inhibitors-market Market Coverage •Market number available for – 2019-2026 •Base year- 2019 •Forecast period- 2020-2026 •Segment Covered- By Type •Regions Covered- North America, Europe, Asia-Pacific, Rest of the World •Competitive Landscape- Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Merck & Co., Eli Lily & Co., GlaxoSmithKline Plc, LG Life Sciences Ltd., Novartis AG, Phenomix Corp., and Takeda Pharmaceutical Co. among others Global Dipeptidyl peptidase 4 (DPP-4) inhibitors Market – Segmentation By Type •Sitagliptin •Vildagliptin •Saxagliptin •Linagliptin

3. •Gemigliptin •Anagliptin •Teneligliptin •Others Global Dipeptidyl peptidase 4 (DPP-4) inhibitors Market – Segmentation by Region North America •United States •Canada Europe •UK •Germany •Italy •Spain •France •Rest of Europe Asia-Pacific •China •India •Japan •South Korea •Rest of Asia-Pacific Rest of the World Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For https://www.omrglobal.com/report-customization/dipeptidyl-peptidase-4-inhibitors- market More Customized Data, Request for Report Customization @ About Orion Market Research

4. Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 780-304-0404